Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral atorvastatin for inflammatory factors in traumatic brain injury
IRCT20191016045127N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Leukocytosis, Leukocytopenia and 3 more. Started Jan 2020; status: completed.
02
Drugs
atorvastatin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20191016045127N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191016045127N1.